The Global Burden of Disease Study estimated a 60% to 70% lifetime prevalence of chronic non-specific low back pain (CNSLBP) in industrialized countries with 19% of American adults over age 45 suffering from Knee Osteoarthritis (KOA). In conjunction, opioid prescription rose from 76 million to 219 million between 1991 and 2013, making the US the largest consumer of opioids globally with increasing opioid-related emergency room visits, treatment admissions, and overdose fatalities.
A non-invasive FGBM device, AposTherapy, has had efficacy in relieving pain and improving function in patients with KOA and CNSLBP. This study evaluated the effect of FGBM on the use of prescription opioids in patients with CNSLBP and KOA
To determine whether Footwear Generated Biomechanical Manipulation (FGBM) of gait can decrease opioid prescriptions filled in patients with CNSLBP and KOA.
A significant decrease in opioid prescriptions was seen in all OA and CNSLBP patients. At 12 months prescriptions for opioids decreased by 13.1% (n=73, p = 0.0002). This was greatest for patients with CNSLBP, with a 20% decrease in prescribed opioids (n=53, p=0.0001).
This study demonstrates the effect of the therapy on the reduction of usage of prescription opioids by patients who have been treated with FGBM, confirming the benefits shown in previous studies where FGBM (AposTherapy) has decreased discomfort and improved gait speed for patients suffering from KOA and CNSLBP.
Sadee Ghasempour Soleymani– Research Fellow, Montefiore Medical Ceter
Jasal Patel– Research fellow, Montefiore Medical center
Vikram Madan– Research Associate, Montefiore Medical Center
Beendu Pujar– Research Fellow, Burke Hospital
Matthew Bartels– Professor and Chairman, Montefiore Medical Center/Albert Einstein College of Medicine